Market News Archives

When ‘Seed’ Means $1 Billion: AMI Labs and the New Math of Frontier AI -( $NVDA )

by John F. Heerdink, Jr. March 11, 2026 445Views 0Likes

For an institutional and VC audience, AMI Labs looks less like a moonshot and more like a well-capitalized, asymmetric bet on a new layer of the AI stack—“world models” that could sit beneath, or alongside, today’s large language models. AMI Labs: A…

Richest People on Earth: The Ultimate Stock‑Powered Wealth League (Mars Not Included) – ( $AMZN $DELL $GOOGL $ITX $META $MSFT $NVDA $TSLA )

by John F. Heerdink, Jr. March 11, 2026 610Views 0Likes

Elon Musk may be racing rockets to Mars, but on Earth he is lapping the billionaire field by several orbits—and the scoreboard has rarely looked this lopsided. A New Gilded Age, With One Clear Front‑Runner According to recent billionaire tallies, global wealth…

GeoVax Joins the “Post‑Prasad” Party With a Well‑Timed Signal to Buyers and Bureaucrats -( $GOVX $INO $TNXP $VRTX $IBB $XBI )

by John F. Heerdink, Jr. March 11, 2026 498Views 0Likes

The timing could hardly be better: as controversial FDA leader, Vinay Prasad, exits FDA’s CBER and sentiment tilts back toward innovation, GeoVax Labs (NASDAQ: GOVX) has launched formal outreach around future procurement of its GEO‑MVA mpox/smallpox vaccine. The company is effectively telling…

March 10, 2026 – Nasdaq Hides In The Server Room While Crude Kicks Over The Furniture -( $EPRX $FIGS $GOVX $HIMS $MODD $NVDA $ORCL $SOAR $VRTX Rise!)

by John F. Heerdink, Jr. March 10, 2026 2304Views 0Likes

US stocks chopped sideways into the close Tuesday as oil’s historic round‑trip kept nerves frayed, leaving the Dow and S&P 500 slightly lower while the Nasdaq clung to a fractional .01% gain and traders tried to game the next headline out of…

Mira Murati’s Thinking Machines: The AI Lab That Raised Billions Before Saying “Hello, World” -( $AMD $CSCO $NVDA )

by John F. Heerdink, Jr. March 10, 2026 456Views 0Likes

In a funding climate where many startups now need revenue, a roadmap, and perhaps a minor miracle to get a Series A, Mira Murati’s Thinking Machines Lab just secured roughly $2 billion at a $12 billion valuation before launching a single product.…

Oklo and Centrus Fire Up Piketon: Nuclear’s New Power Couple in Ohio-( $LEU $OKLO )

by John F. Heerdink, Jr. March 10, 2026 410Views 0Likes

Oklo’s planned joint venture with Centrus (LEU) reads less like a routine fuel contract and more like a quiet inflection point for America’s nuclear comeback story. Nuclear’s New Power Couple in Piketon In southern Ohio, two neighbors are plotting a distinctly 21st‑century…

Oil’s 4‑Year High Hangover: How Crude Went From Panic to Pullback Overnight -( $BNO $USO $VDE $XLE )

by John F. Heerdink, Jr. March 9, 2026 605Views 0Likes

Oil’s latest whiplash session today delivered a rare gift to anxious markets: a reminder that even in wartime, panic pricing has a half‑life. Oil Soars, Then Sinks: A War Premium With Stage Fright Brent and West Texas Intermediate futures briefly sprinted above…

March 9, 2026 – Wall Street Ducks a Bullet: Markets Rebound as Oil Loses Its Nerve -( $GOVX $HIMS $INTG $NOK $NVDA $OPEN $XENE Rise!)

by John F. Heerdink, Jr. March 9, 2026 2223Views 0Likes

U.S. stocks staged a dramatic intraday reversal on Monday, March 9, 2026, with the major indexes erasing steep early losses as oil prices retreated from their highs and investors latched onto signs the Iran conflict might deescalate. Indexes: From Rout To Rebound…

From Chips to Kilowatts: Vertiv, NVIDIA and Nokia Quietly Rewire the AI Boom -( $NOK $NVDA $VRT )

by John F. Heerdink, Jr. March 9, 2026 624Views 0Likes

Vertiv’s (VRT) latest move reads like a front‑page Wall Street story for the AI era: a power-and-cooling heavyweight teaming with a deep‑pocketed infrastructure investor to keep NVIDIA‑class data centers humming in markets where the grid is already wheezing. Vertiv, Generate Capital and…

Wegovy Goes Online, Insulin Goes Tubeless: Why Metabolic Care Suddenly Looks Sexy -( $HIMS $MODD $NVO )

by John F. Heerdink, Jr. March 9, 2026 483Views 0Likes

Hims & Hers (HIMS) just turned a courtroom drama into a growth story and its stock has flown +40% higher today, and a little-known insulin pump maker may be quietly scripting the sequel in metabolic health. Hims & Hers: From GLP-1 Outlaw…

Market News

Your Guide To Staying Informed In The Markets